Ali H, Bacigalupo A. 2024 update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management. Am J Hematol. 2024;99(5):938–45.

Article  CAS  PubMed  Google Scholar 

Bai L, Zhang ZX, Hu GH, Cheng YF, Suo P, Wang Y, et al. Long-term follow-up of haploidentical haematopoietic stem cell transplantation in paediatric patients with high-risk acute myeloid leukaemia: Report from a single centre. Br J Haematol. 2023;204(2):585–94.

Article  PubMed  Google Scholar 

Berning P, Schmitz N, Ngoya M, Finel H, Boumendil A, Wang F, et al. Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: An international collaborative analysis. Leukemia. 2023;37(7):1511–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elmakaty I, Saglio G, Al-Khabori M, Elsayed A, Elsayed B, Elmarasi M, et al. The contemporary role of hematopoietic stem cell transplantation in the management of chronic myeloid leukemia: Is it the same in all settings? Cancers. 2024;16(4).

Shang Q, Bai L, Cheng Y, Suo P, Hu G, Yan C, et al. Outcomes and prognosis of haploidentical haematopoietic stem cell transplantation in children with FLT3-ITD mutated acute myeloid leukaemia. Bone Marrow Transplantation. 2024.

Wu L, Wu Y, Shi J, Lai X, Zhao Y, Liu L, et al. Survival and late mortality among patients who survived disease-free for 2 years after stem cell transplantation. Br J Haematol. 2023;202(3):608–22.

Article  CAS  PubMed  Google Scholar 

Xu Z-L, Xu L-P, Zhang Y-C, Zhou Y-H, Jiang E-L, Zhang J-P, et al. The outcome and predictive model of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia from the Chinese Blood and Marrow Transplant Registry Group. Haematologica. 2024.

Chang YJ, Luznik L, Fuchs EJ, Huang XJ. How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation? J Hematol Oncol. 2016;9:35.

Article  PubMed  PubMed Central  Google Scholar 

Gale RP, Eapen M. Who is the best alternative allotransplant donor? Bone Marrow Transplant. 2015;50(S2):S40–2.

Article  PubMed  PubMed Central  Google Scholar 

Nagler A, Labopin M, Mielke S, Passweg J, Blaise D, Gedde-Dahl T, et al. Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: A study from the ALWP/EBMT. Bone Marrow Transplant. 2023;58(7):791–800.

Article  PubMed  Google Scholar 

Wang Y, Wu DP, Liu QF, Xu LP, Liu KY, Zhang XH, et al. Donor and recipient age, gender and ABO incompatibility regardless of donor source: Validated criteria for donor selection for haematopoietic transplants. Leukemia. 2017;32(2):492–8.

Article  PubMed  Google Scholar 

Xu LP, Wang SQ, Ma YR, Gao SJ, Cheng YF, Zhang YY, et al. Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study. J Hematol Oncol. 2019;12(1):87.

Article  PubMed  PubMed Central  Google Scholar 

Passweg JR, Baldomero H, Ciceri F, Corbacioglu S, de la Cámara R, Dolstra H, et al. Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey. Bone Marrow Transplantation. 2023;58(6):647–658.

Chang Y-J, Pei X-Y, Huang X-J. Haematopoietic stem-cell transplantation in China in the era of targeted therapies: Current advances, challenges, and future directions. Lancet Haematology. 2022;9(12):e919–29.

Article  CAS  PubMed  Google Scholar 

CIBMTR. The US summary slides—HCTtrends and survival data. 2022. [Available from: https://cibmtr.org/CIBMTR/Resources/Summary-Slides-Reports.

Bramanti S, Calafiore V, Longhi E, Mariotti J, Crespiatico L, Sarina B, et al. Donor-specific anti-HLA antibodies in haploidentical stem cell transplantation with post-transplantation cyclophosphamide: Risk of graft failure, poor graft function, and impact on outcomes. Biol Blood Marrow Transplant. 2019;25(7):1395–406.

Article  CAS  PubMed  Google Scholar 

Lima ACM, Getz J, do Amaral GB, Loth G, Funke VAM, Nabhan SK, et al. Donor-specific HLA antibodies are associated with graft failure and delayed hematologic recovery after unrelated donor hematopoietic cell transplantation. Transplantation and Cellular Therapy. 2023;29(8):493.e491–493.e410.

Ozdemir ZN, Civriz BS. Graft failure after allogeneic hematopoietic stem cell transplantation. Transfus Apheres Sci. 2018;57(2):163–7.

Article  Google Scholar 

Huang XJ. Overcoming graft failure after haploidentical transplantation: Is this a possibility? Best Pract Res Clin Haematol. 2021;34(1): 101255.

Article  CAS  PubMed  Google Scholar 

Barge AJ, Johnson G, Witherspoon R, Torok-Storb B. Antibody-mediated marrow failure after allogeneic bone marrow transplantation. Blood. 1989;74(5):1477–80.

Article  CAS  PubMed  Google Scholar 

Chang Y-J, Xu L-P, Wang Y, Zhang X-H, Chen H, Chen Y-H, et al. Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody. Bone Marrow Transplant. 2020;55(7):1326–36.

Article  CAS  PubMed  Google Scholar 

Ciurea SO, Al Malki MM, Kongtim P, Zou J, Aung FM, Rondon G, et al. Treatment of allosensitized patients receiving allogeneic transplantation. Blood Adv. 2021;5(20):4031–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ciurea SO, Cao K, Fernandez-Vina M, Kongtim P, Malki MA, Fuchs E, et al. The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-Specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation. Bone Marrow Transplant. 2018;53(5):521–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng X, Yan H, Han D, Ding L, Zhu L, Liu J, et al. Successful desensitization of high level donor-specific anti-HLA antibody in patients with hematological diseases receiving haploidentical allografts. Ann Hematol. 2022;101(8):1777–83.

Article  CAS  PubMed  Google Scholar 

Ma N, Wu WB, Zhao XY, Xu LP, Zhang XH, Wang Y, et al. Targeting T(FH) cells is a novel approach for donor-specific antibody desensitization of allograft candidates: An in vitro and in vivo study. Haematologica. 2024;109(4):1233–46.

CAS  PubMed  Google Scholar 

Ma N, Wang ZD, Sun YQ, Yan CH, Wang FR, Mo XD, et al. Effect of sirolimus combined with anti-CD20 monoclonal antibody desensitization on the prognosis of patients underwent haploidentical stem cell transplantation. Zhonghua Yi Xue Za Zhi. 2024;104(11):843–9.

CAS  PubMed  Google Scholar 

Zhang Z, Markmann C, Yu M, Agarwal D, Rostami S, Wang W, et al. Immunotherapy targeting B cells and long-lived plasma cells effectively eliminates pre-existing donor-specific allo-antibodies. Cell Rep Med. 2023;4(12): 101336.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Middelburg RA, Porcelijn L, Lardy N, Briët E, Vrielink H. Prevalence of leucocyte antibodies in the Dutch donor population. Vox Sang. 2010;100(3):327–35.

Article  PubMed  Google Scholar 

Endres RO, Kleinman SH, Carrick DM, Steele WR, Wright DJ, Norris PJ, et al. Identification of specificities of antibodies against human leukocyte antigens in blood donors. Transfusion. 2010;50(8):1749–60.

Article  PubMed  PubMed Central  Google Scholar 

Kakaiya RM, Triulzi DJ, Wright DJ, Steele WR, Kleinman SH, Busch MP, et al. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion. 2010;50(6):1328–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Clippel D, Baeten M, Torfs A, Emonds MP, Feys HB, Compernolle V, et al. Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy. Transfusion. 2014;54(12):3036–42.

Article  PubMed  Google Scholar 

Masson E, Vidal C, Deschamps M, Bongain S, Thevenin C, Dupont I, et al. Incidence and risk factors of anti-HLA immunization after pregnancy. Hum Immunol. 2013;74(8):946–51.

Article  CAS  PubMed  Google Scholar 

Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: Implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion. 2009;49(9):1825–35.

Article  PubMed  PubMed Central  Google Scholar 

Akgul SU, Ciftci HS, Temurhan S, Caliskan Y, Bayraktar A, Tefik T, et al. Association between HLA antibodies and different sensitization events in renal transplant candidates. Transpl Proc. 2017;49(3):425–9.

Article  CAS  Google Scholar 

Hung S-Y, Lin T-M, Chang M-Y, Wang H-H, Lee Y-C, Ho L-C, et al. Risk factors of sensitization to human leukocyte antigen in end-stage renal disease patients. Hum Immunol. 2014;75(6):531–5.

Article